25 January 2013
Research reported at the Society of Critical Care Medicine
meeting found that people who are vitamin D deficient have an increased risk of
developing sepsis – a severe blood infection – and an increased risk of death
if they develop sepsis.
Kenneth Christopher, MD, of Brigham and Women’s Hospital in
Boston reported that people who had low vitamin D levels prior to being
admitted to the hospital were significantly more likely to develop sepsis after
hospitalization compared to patients with normal vitamin D levels. Among
patients who developed sepsis, the odds of dying within 30 days was greater for
people with deficient or insufficient vitamin D blood levels.
Dr Christopher and colleagues analyzed data from 3,400 adult
patients who received care in the ICU at two Boston hospitals from 1998 to 2011
who had vitamin D blood test up to a year prior to hospitalization. Within 12
months, 26% of patients died. The authors found that the mortality rate was
higher for those with sepsis, reaching 44.6%. Vitamin D deficiency
pre-admission was significantly associated with sepsis, an association which
remained after correcting for confounders.
Another study presented by Bryan Nguyen, MD, of Loma Linda
University in California offered support to the Boston research.
Dr Nguyen and colleagues uncovered a related link between
vitamin D status and an increased mortality risk in patients with sepsis. They
analyzed the link between vitamin D levels in the first 72 hours of hospitalization
and 30-day mortality in patients with sepsis. The study included 91 emergency
room patients who were admitted to the ICU. Eleven percent of the patients died
within 30 days.
The patients who died had significantly lower vitamin D
levels at admission, compared to those who survived the first 30 days (p=0.04).
Interestingly, parathyroid hormone levels were significantly higher among
patients who died within the first 3 days in the ICU.
The researchers are cautious to celebrate vitamin D as a cure-all
for sepsis, but they support its potential ability to expedite recovery time.
Nguyen concludes that the study “does suggest that 1,25(OH)2D
may be a viable therapeutic target in the design of future sepsis clinical
trials while we're trying to tease out the various mechanisms of vitamin D
deficiency in these patients."
Source
No comments:
Post a Comment